An invasive ductal carcinoma was diagnosed by core needle biopsy of the lesion and the tumor was estrogen receptor (ER)-negative, progesterone receptor (PgR)-negative, human epidermal growth factor receptor 2 (Her2)-positive (+++), and Ki-67 50%. This evidence concerns the gene ERBB2 and invasive ductal breast carcinoma.